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See related commentary by Scales and Cuthbertson, http://ccforum.com/content/18/2/117We read with great interest the article by Scales and
Cutherbertson on percutaneous dilatational tracheostomy
in a previous issue of Critical Care [1]. In particular, we
appreciated their last comment: ‘Finally, we believe that
some patient populations - for example, those with chronic
respiratory conditions or underlying neurological injury -
may have risk-benefit profiles that differ from general ICU
patients, and this should be further explored’. We whole-
heartedly agree with their statement about neurosciences
intensive care unit (NeuroICU) patients in particular be-
cause patients with traumatic brain injury or poor-grade
subarachnoid hemorrhage can develop global cerebral
edema (GCE), which may peak within the first few days
and can last up to 2 weeks - refractory intracranial pressure
(ICP) - without advanced intervention or decompressive
hemicraniectomy or both. We have found that GCE
patients with refractory ICP may be better served by having
earlier tracheostomy if the primary brain injury is survivable
and the patients have a reasonable prognosis but that it
may be wise to wait longer if the prognosis is indetermin-
ate, as the authors mention the risks versus benefit. Finally,
we have studied the ICP surge during the dilatational part
of percutaneous tracheostomies in our NeuroICU with
indwelling ICP monitors [2]. For the most part, we safely
managed ICP with mannitol or hypertonic saline or by
opening the ventriculostomy drain to allow ventricular fluid
out in order to lower ICP during the procedure. Prior to
this study, we found little to no information about the
safety of this procedure in this group of patients. Therefore,
we agree with the authors that a specific risk-versus-benefit
ratio of subsets of ICU patients should be analyzed with
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